The Trendlines Group (Trendlines) (SGX:42T
) announced that its portfolio company, NICE Surgical Solutions Pte Ltd (NICE Surgical), a clinical-stage medical device company, has been officially granted the US patent for its purse-string stapler.
NICE Surgical is based in Singapore and incubated by Trendlines’ subsidiary, Trendlines Medical Singapore.
According to Trendlines, this patented technology enables colorectal surgery to be completed non-invasively, without an incision to the abdomen, as currently practiced. The use of NICE Surgical’s device potentially increases the efficiency in surgery and reduces surgical site infections, usually associated with surgical incisions.
“This patent is a testament to the dedication and ingenuity of the research and development team at NICE Surgical. With NICE Surgical’s development progression, including human clinical studies by Q4 2026, this milestone further strengthens the validated technology,” says Haim Brosh, CEO of Trendlines.
Shares of Trendlines closed 0.1 cent higher, or 1.72% up at 5.9 cents on July 3.
